Literature DB >> 28892458

Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.

Takeshi Yokoo1, Suraj D Serai1, Ali Pirasteh1, Mustafa R Bashir1, Gavin Hamilton1, Diego Hernando1, Houchun H Hu1, Holger Hetterich1, Jens-Peter Kühn1, Guido M Kukuk1, Rohit Loomba1, Michael S Middleton1, Nancy A Obuchowski1, Ji Soo Song1, An Tang1, Xinhuai Wu1, Scott B Reeder1, Claude B Sirlin1.   

Abstract

Purpose To determine the linearity, bias, and precision of hepatic proton density fat fraction (PDFF) measurements by using magnetic resonance (MR) imaging across different field strengths, imager manufacturers, and reconstruction methods. Materials and Methods This meta-analysis was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A systematic literature search identified studies that evaluated the linearity and/or bias of hepatic PDFF measurements by using MR imaging (hereafter, MR imaging-PDFF) against PDFF measurements by using colocalized MR spectroscopy (hereafter, MR spectroscopy-PDFF) or the precision of MR imaging-PDFF. The quality of each study was evaluated by using the Quality Assessment of Studies of Diagnostic Accuracy 2 tool. De-identified original data sets from the selected studies were pooled. Linearity was evaluated by using linear regression between MR imaging-PDFF and MR spectroscopy-PDFF measurements. Bias, defined as the mean difference between MR imaging-PDFF and MR spectroscopy-PDFF measurements, was evaluated by using Bland-Altman analysis. Precision, defined as the agreement between repeated MR imaging-PDFF measurements, was evaluated by using a linear mixed-effects model, with field strength, imager manufacturer, reconstruction method, and region of interest as random effects. Results Twenty-three studies (1679 participants) were selected for linearity and bias analyses and 11 studies (425 participants) were selected for precision analyses. MR imaging-PDFF was linear with MR spectroscopy-PDFF (R2 = 0.96). Regression slope (0.97; P < .001) and mean Bland-Altman bias (-0.13%; 95% limits of agreement: -3.95%, 3.40%) indicated minimal underestimation by using MR imaging-PDFF. MR imaging-PDFF was precise at the region-of-interest level, with repeatability and reproducibility coefficients of 2.99% and 4.12%, respectively. Field strength, imager manufacturer, and reconstruction method each had minimal effects on reproducibility. Conclusion MR imaging-PDFF has excellent linearity, bias, and precision across different field strengths, imager manufacturers, and reconstruction methods. © RSNA, 2017 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 2, 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28892458      PMCID: PMC5813433          DOI: 10.1148/radiol.2017170550

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  88 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

4.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

Authors:  Arun J Sanyal; Colin Banas; Carol Sargeant; Velimir A Luketic; Richard K Sterling; Richard T Stravitz; Mitchell L Shiffman; Douglas Heuman; Adrian Coterrell; Robert A Fisher; Melissa J Contos; Alan S Mills
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

6.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

7.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Authors:  Vlad Ratziu; Frédéric Charlotte; Agnès Heurtier; Sophie Gombert; Philippe Giral; Eric Bruckert; André Grimaldi; Frédérique Capron; Thierry Poynard
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

8.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

9.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

10.  The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.

Authors:  Penny Whiting; Anne W S Rutjes; Johannes B Reitsma; Patrick M M Bossuyt; Jos Kleijnen
Journal:  BMC Med Res Methodol       Date:  2003-11-10       Impact factor: 4.615

View more
  76 in total

1.  Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Peter Johannes Wagenhäuser; Michael Meier-Schroers; Daniel Lloyd Kuetting; Andreas Feißt; Jürgen Gieseke; Leonard Christopher Schmeel; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

2.  Proton density fat fraction (PDFF) MR imaging for differentiation of acute benign and neoplastic compression fractures of the spine.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Simon Jonas Enkirch; Andreas Feißt; Christoph Hans-Jürgen Endler; Leonard Christopher Schmeel; Peter Johannes Wagenhäuser; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

3.  Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.

Authors:  Charlie C Park; Catherine Hooker; Jonathan C Hooker; Emily Bass; William Haufe; Alexandra Schlein; Yesenia Covarrubias; Elhamy Heba; Mark Bydder; Tanya Wolfson; Anthony Gamst; Rohit Loomba; Jeffrey Schwimmer; Diego Hernando; Scott B Reeder; Michael Middleton; Claude B Sirlin; Gavin Hamilton
Journal:  J Magn Reson Imaging       Date:  2018-04-29       Impact factor: 4.813

4.  Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.

Authors:  An Tang; François Destrempes; Siavash Kazemirad; Julian Garcia-Duitama; Bich N Nguyen; Guy Cloutier
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

5.  Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise.

Authors:  Cheng William Hong; Gavin Hamilton; Catherine Hooker; Charlie C Park; Calvin Andrew Tran; Walter C Henderson; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin
Journal:  Abdom Radiol (NY)       Date:  2019-10

Review 6.  Imaging Modalities in Pediatric NAFLD.

Authors:  Suraj D Serai; Jennifer Panganiban; Manish Dhyani; Andrew J Degnan; Sudha A Anupindi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 7.  Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions.

Authors:  Rohit Loomba
Journal:  J Hepatol       Date:  2017-12-02       Impact factor: 25.083

8.  Free-breathing liver fat and R 2 quantification using motion-corrected averaging based on a nonlocal means algorithm.

Authors:  Huiwen Luo; Ante Zhu; Curtis N Wiens; Jitka Starekova; Ann Shimakawa; Scott B Reeder; Kevin M Johnson; Diego Hernando
Journal:  Magn Reson Med       Date:  2020-08-01       Impact factor: 4.668

Review 9.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

10.  Motion-robust, high-SNR liver fat quantification using a 2D sequential acquisition with a variable flip angle approach.

Authors:  Ruiyang Zhao; Yuxin Zhang; Xiaoke Wang; Timothy J Colgan; Jennifer L Rehm; Scott B Reeder; Kevin M Johnson; Diego Hernando
Journal:  Magn Reson Med       Date:  2020-04-03       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.